https://www.selleckchem.com/pr....oducts/fingolimod.ht
BACKGROUND Continued high mortality in heart failure patients indicates the need for additional methods of risk stratification and phenotyping. HYPOTHESIS We hypothesized that ventricular arrhythmias that do not meet test-termination criteria (non-terminating ventricular arrhythmias [NTVA]) during cardiopulmonary exercise testing (CPET) may help in phenotyping disease severity and prognosis in heart failure with reduced (HFrEF) and midrange (HFmrEF)/preserved (HFpEF) left ventricular ejection fraction (LVEF). METHODS About 319 patien
Like
Comment
Share
